Life Science Investment Day Scandinavia. March 27, 2012.



Welcome and introduction

Jonas Ekstrand, SwedenBIO
Claes Hemberg, Avanza
Pia Kinhult, First Governor Region Skåne



Keynote Presentation: Bird&Bird

Hans Svensson, Partner and
Ludo M. Deklerck, Partner, Bird&Bird



International Investor Session - Who we are and what we want!

Investors and Business Partners



VINNOVA – Challenge driven innovation for future health

Jenni Nordborg, Head of Department, acting Director of Health, VINNOVA,
The Swedish Governmental Agency for Innovation Systems



EU FP 7 Funding Opportunities

Björn Kull, Senior Manager, EU Support Office, SwedenBIO



Turning molecules into products

Torkel Gren, Sales Director, Recipharm Pharmaceutical Development




Active Deal Flow Management – paving the ground for successful life science companies

Björn Larsson, Business Development & Investment Manager, GU Holding



How to attract an Investor

David Dible, Senior Director, Citigate Dewe Rogerson



Venture capital in the Malmö-Lund Region: current status and reflections on the Future

Ulf G Andersson, CEO, Det Medicinska Malmö



Intellectual Asset Management ; Get value from your patents - connect patents with business development

Tomas Lundquist, Awapatent



Turning IPR into cash: Successful licensing & distribution strategies for Japan
Tanja Dowe, Managing Partner, Innomedica Ltd.



Export and Financing into new geographical areas - Sweden in a unique position to expand

Gunnar Boström, Export Director, Phil Med Alliance



Emerging market opportunities: China

Grace Chen, Partner, Bird&Bird, Bejing, China



Licensing at MSD
Erik Lund, Director Scientific Liaison Scandinavia, Eastern EU and Turkey



AstraZeneca partnering strategies

Michael Vestling, Business Development Manager, CNS Pain



Boosting Medicon Valley into a World-Class Life Science Region

Anna Chérouvrier Hansson, Head of Life Science, Invest in Skåne
and Stig Jørgenssen, CEO, Medicon Valley Alliance



Medicon Village, MAX4 and ESS – new facilities for Life Science in Scandinavia and Europe

Allan Larsson, Former Minister of Finance, Chairman University of Lund, Board Director Mats Paulssons stiftelse



Incentives for the Scandinavian Life Science Industry – a comparative study

Erica Monfardini, PwC Luxemburg



UK’s new Life Science Strategy - opportunities for Scandinavian companies

Nigel Whittle, Technology Specialist, Life Sciences, UK Trade & Investment



Panel Discussion – Enabling Success for Scandinavian Life Science Companies



Concluding remarks
Erik Walldén, Chairman SwedenBIO Business & Finance working group


Index